PMI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Picard Medical Inc. (PMI) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is facing significant legal and reputational challenges due to allegations of fraudulent activities and class action lawsuits. Additionally, the technical indicators and financial performance do not support a strong investment case at this time.
The technical indicators show a bearish trend with moving averages (SMA_200 > SMA_20 > SMA_5) indicating downward momentum. RSI is neutral at 36.185, and the MACD histogram is above zero but positively contracting. Key support levels are at 0.943 and 0.886, with resistance at 1.037 and 1.131. Overall, the stock is in a weak technical position.
Revenue increased by 34.73% YoY in Q3 2025, and net income improved by 51.34% YoY, showing some operational progress.
The company is embroiled in multiple class action lawsuits related to fraudulent stock promotion schemes and corporate governance issues. The stock price has suffered a significant drop (70% on October 24, 2025), and investor sentiment is highly negative. Gross margin dropped significantly (-85.67% YoY), and EPS remains negative.
In Q3 2025, revenue increased to $1,187,000 (up 34.73% YoY), but the company reported a net loss of $10,426,000 (up 51.34% YoY). EPS improved to -0.14 (up 40% YoY), but gross margin dropped to -10.95% (down -85.67% YoY), indicating operational inefficiencies.
No analyst rating or price target changes are provided. However, Wall Street sentiment is likely negative due to ongoing legal and reputational issues.
